Recombinant Human IL-17A
- Cat. No.：EPT053
- Price：Negotiable
- Clicks：1147
Product Detail
Basic Information
| Size | 10ug |
|---|---|
| Expression Host | E.coli |
| Tag | NA |
Physical Properties
| Molecular Weight | 15.26 KDa |
|---|---|
| Apparent Molecular Weight | 16 KDa, reducing conditions |
| Form | Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
| Purity | Greater than 95% as determined by reducing SDS-PAGE. |
Activity & Endotoxin
| Endotoxin Level | Less than 0.1 ng/µg (1 EU/µg) as determined by LAL test. |
|---|---|
| Activity | Immobilized Human IL-17A(Cat#C021) at 2μg/ml (100 μl/well) can bind Anti-Human IL-17A mAb(Cat#NC012).The ED50 of Anti-Human IL-17A mAb(Cat#NC012) is 0.185 ug/ml. |
Storage & Shipping
| Reconstitution | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
|---|---|
| Storage | Lyophilized protein should be stored at < -20°C, though stable at room temperature for 3 weeks. Reconstituted protein solution can be stored at 4-7°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months. |
| Shipping Condition | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature listed below. |
Detailed Description
| Background | Interleukin-17 is a potent pro-inflammatory cytokine produced by activated memory T cells. There are at least six members of the IL-17 family in humans and in mice. As IL-17 shares properties with IL-1 and TNF-alpha, it may induce joint inflammation and bone and cartilage destruction. This cytokine is found in synovial fluids of patients with rheumatoid arthritis, and produced by rheumatoid arthritis synovium. It increases IL-6 production, induces collagen degradation and decreases collagen synthesis by synovium and cartilage and proteoglycan synthesis in cartilage. IL-17 is also able to increase bone destruction and reduce its formation. Blocking of interleukin-17 with specific inhibitors provides a protective inhibition of cartilage and bone degradation. |
|---|
Related Products:
| Product Name | Clicks |
|---|---|
| 三甲氧苄氨嘧啶（TMP）-BSA（或OVA）抗原 | 5046 |
| 氰菊酯-BSA（或OVA）抗原 | 5078 |
| 黄曲霉毒素M1-BSA抗原 | 4894 |
| 黄曲霉毒素B1-BSA抗原 | 4489 |
| 喹烯酮-BSA（或OVA）抗原 | 5015 |
| 磺胺氯吡嗪-BSA（或OVA）抗原 | 5245 |
| 阿西美辛-BSA（或OVA）抗原 | 4977 |
| 吲哚美辛-BSA（或OVA）抗原 | 4978 |
| 氯吡脲-BSA（或OVA）抗原 | 4997 |
| 马杜霉素-BSA（或OVA）抗原 | 5011 |
| 炔诺酮-BSA（或OVA）抗原 | 5268 |
| 万古霉素-BSA抗原 | 5055 |
| 呋喃苯烯酸钠-BSA（或OVA）抗原 | 4971 |
| 雌酮-BSA（或OVA）抗原 | 5115 |
| 安乃近-BSA（或OVA）抗原 | 5219 |
| 司帕沙星-BSA（或OVA）抗原 | 5077 |
| 妥布霉素-BSA抗原 | 4888 |
| 甲氧氯普胺-BSA（或OVA）抗原 | 5025 |
| 他达那非-BSA（或OVA）抗原 | 5167 |
| 皮质醇（氢化可的松）-BSA（或OVA）抗原 | 5087 |